Five things for pharma marketers to know: Thursday, September 21, 2017
Galderma's Restylane uses non-animal stabilized hyaluronic acid.
1. Nestle said it will get rid of 450 out of 550 jobs at a Galderma R&D center in France. The skin health business has underperformed, and Nestle plans to refocus its R&D on injections or oral products rather than prescription creams. (Reuters)
2. Amazon is reportedly in talks with pharmacy benefit managers, analysts have said. The company is considering getting into the mail-order pharmacy sector, with plans to target uninsured people or those with high deductibles. (Axios)
3. Most Americans do not intentionally read science news, according to a new study. About one-third say they read science news a few times a week, and another third say they actively seek out that kind of news. (Pew Research Center)
4. Despite Sanofi's recent reliance on partner Regeneron Pharmaceuticals' pipeline, Sanofi R&D chief Elias Zerhouni told investors that he believes that the French drugmaker's in-house research unit is strong enough to stand alone. (Endpoints News)
5. Orig3n, a biotechnology firm, plans to give out free DNA testing kits at a Baltimore Ravens' game. The free test examines four genes, including one that can mean a person has “enhanced performance in power and sprint activities.” (Baltimore Sun)